Gosmanova Elvira O, Kovesdy Csaba P
Nephrology Division, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Nephrology Division, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, TN, USA.
Nephrol Dial Transplant. 2015 Oct;30(10):1649-56. doi: 10.1093/ndt/gfu330. Epub 2014 Oct 21.
Significant progress has been made in the management of hypertension (HTN) in the last 60 years. A large number of antihypertensive drugs (AHD) is available for effective control of elevated blood pressure (BP) that were also shown to be beneficial in improving all-cause mortality and cardiovascular morbidity in hypertensive individuals. Despite these successes, rates of BP control and outcomes in hypertensive patients remain suboptimal. Therefore, the availability of effective drug therapy itself appears to be insufficient to guarantee desirable results. Adherence to antihypertensive medications is a crucial mediator of favorable outcomes in treating HTN, and non-adherence, in turn, halts BP control. In this review, we will summarize the available evidence on health-related impacts of adherence to AHD, methods for the evaluation of adherence and potential interventions aimed to improve adherence in hypertensive individuals.
在过去60年里,高血压(HTN)管理取得了重大进展。大量抗高血压药物(AHD)可用于有效控制血压升高,这些药物还被证明有助于改善高血压患者的全因死亡率和心血管发病率。尽管取得了这些成功,但高血压患者的血压控制率和治疗结果仍不尽人意。因此,有效的药物治疗本身似乎不足以保证理想的治疗效果。坚持服用抗高血压药物是治疗高血压取得良好效果的关键因素,而不坚持服药则会阻碍血压控制。在本综述中,我们将总结关于坚持服用抗高血压药物对健康相关影响的现有证据、评估坚持服药情况的方法以及旨在提高高血压患者服药依从性的潜在干预措施。